<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn>
  <p>Alexandra Dumitriu and Javad Golji contributed equally to this work.</p>
 </fn>
 <fn>
  <p>
   <bold>Electronic supplementary material</bold>
  </p>
  <p>The online version of this article (doi:10.1186/s12920-016-0164-y) contains supplementary material, which is available to authorized users.</p>
 </fn>
 <fn>
  <p>
   <bold>Competing interests</bold>
  </p>
  <p>Alexandra Dumitriu, Adam T. Labadorf, Thomas G. Beach, Richard H. Myers, and Jeanne C. Latourelle declare that they have no competing interests. Kenneth Longo, Javad Golji and Benbo Gao are currently (KL) or were previously (JG, BG) employed at Proteostasis Therapeutics, Inc. Kenneth Longo holds options to purchase shares in Proteostasis Therapeutics, Inc.</p>
  <p>Proteostasis Therapeutics, Inc. does not hold, nor is it currently applying for, any patents relating to the content of this manuscript. Proteostasis Therapeutics, Inc. has not received reimbursements, fees, funding, or salary from any organization that holds or has applied for patents relating to the content of this manuscript.</p>
 </fn>
 <fn>
  <p>
   <bold>Authorsâ€™ contributions</bold>
  </p>
  <p>AD and JG carried out the analyses of the proteomics, RNA-sequencing, SNP genotyping, and microarray data. ATL assisted in the analysis of the RNA-sequencing data. BG and KAL assisted in the analysis of the proteomics data. TGB provided post-mortem tissue samples and relevant neuropathological and clinical data for samples studied. RHM, KAL and JCL participated in the design of the study, the interpretation of the results, and the draft of the manuscript. All authors read and approved the final manuscript.</p>
 </fn>
</fn-group>
